MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $66,000 | -5.7% | 2,456 | -36.8% | 0.00% | – |
Q3 2022 | $70,000 | -89.9% | 3,886 | -93.0% | 0.00% | – |
Q2 2022 | $695,000 | -56.0% | 55,911 | -52.8% | 0.00% | – |
Q1 2022 | $1,578,000 | -37.1% | 118,487 | -26.4% | 0.00% | -100.0% |
Q4 2021 | $2,507,000 | -27.6% | 161,022 | +4.4% | 0.00% | 0.0% |
Q3 2021 | $3,461,000 | +8341.5% | 154,233 | +8564.8% | 0.00% | – |
Q2 2021 | $41,000 | +32.3% | 1,780 | +20.3% | 0.00% | – |
Q1 2021 | $31,000 | +138.5% | 1,480 | +211.6% | 0.00% | – |
Q4 2020 | $13,000 | +160.0% | 475 | +26.7% | 0.00% | – |
Q3 2020 | $5,000 | 0.0% | 375 | +70.5% | 0.00% | – |
Q2 2020 | $5,000 | +150.0% | 220 | +10.0% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | -95.5% | 200 | -92.0% | 0.00% | – |
Q3 2018 | $66,000 | – | 2,500 | +83233.3% | 0.00% | – |
Q1 2018 | $0 | – | 3 | +50.0% | 0.00% | – |
Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 2 | -99.1% | 0.00% | – |
Q1 2017 | $3,000 | -57.1% | 230 | -59.5% | 0.00% | – |
Q4 2016 | $7,000 | – | 568 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
Matisse Capital | 32,750 | $508,000 | 0.36% |
VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |